Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience.
about
Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.Pediatric Osteoporosis: Diagnosis and Treatment Considerations.Pharmacological and biological therapeutic strategies for osteogenesis imperfecta.A successful treatment of hypercalcemia with zoledronic acid in a 15-year-old boy with acute lymphoblastic leukemia.Zoledronic acid in pediatric metabolic bone disorders.Developments in rare bone diseases and mineral disorders.Compound heterozygous mutations in COL1A1 associated with an atypical form of type I osteogenesis imperfecta.
P2860
Q38918970-D09FB26E-4A63-43A7-8BB6-1E207B841E30Q38921958-EC92A157-6861-47AD-866D-2A26E25240E0Q38998578-CEC72EA5-19C7-48A3-9F1C-9B890C9B6B5EQ42095964-C562435B-D2BA-40D6-A40F-6B606AF5FFE2Q47139370-B96AE555-7379-48A0-848E-33ECF19643CCQ49413973-C6AEB643-061B-4C5B-963A-CE9376B35483Q53338189-218E9F83-4E80-4B87-A500-49ACC46BB6B1
P2860
Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Short-Term Safety of Zoledroni ...... sive Institutional Experience.
@ast
Short-Term Safety of Zoledroni ...... sive Institutional Experience.
@en
type
label
Short-Term Safety of Zoledroni ...... sive Institutional Experience.
@ast
Short-Term Safety of Zoledroni ...... sive Institutional Experience.
@en
prefLabel
Short-Term Safety of Zoledroni ...... sive Institutional Experience.
@ast
Short-Term Safety of Zoledroni ...... sive Institutional Experience.
@en
P2093
P2860
P356
P1476
Short-Term Safety of Zoledroni ...... nsive Institutional Experience
@en
P2093
Heather M Monk
Kelly Hummel
Paige Kaplan
Sobenna George
P2860
P304
P356
10.1210/JC.2015-2680
P407
P577
2015-08-26T00:00:00Z